share_log

Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Balakrishnan Brinda

SEC ·  May 23, 2024 04:20
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more